2 ASX growth shares I’d buy to aim for big returns

ASX growth shares can make really big returns if things go well. Companies that are growing revenue and seeing rising margins are exciting.

You’re reading a free article on Rask. Join 4,000+ Australians who get our expert advice, tools, exclusive research and investment recommendations. Get your 30-day trial for $1! Learn more

ASX growth shares can make really big returns if things go well. Companies that are growing revenue and seeing rising margins can accelerate returns for investors.

I’d prefer to invest in companies that seem to have many years of growth potential, because that means they can be compounding machines for years to come. Here’s why I like these two ASX growth shares.

Betashares Global Cybersecurity ETF (ASX: HACK)

This exchange-traded fund (ETF) gives Aussie exposure to the global cybersecurity sector. As we’ve seen in Australia over the last year or so, there has been a growing number of high-profile cyber attacks, with victims such as Optus, Medbank Private Ltd (ASX: MPL), IPH Ltd (ASX: IPH) and Latitude Group Holdings Ltd (ASX: LFS).

Governments, businesses, other organisations and individuals need to ensure that their information, intellectual property, internet connection and so on are fully protected against cybercriminals. I believe there’s going to be an increasing need for cybersecurity services over the long-term as more and more things go digital.

I don’t think businesses and governments would not pay for cybersecurity services, even in a recession, so this ETF could have a growing and defensive profile.

The ETF has delivered good returns over the long-term, with net returns of an average of 14% per year over the last five years, and I’m saying the next five years could also be good.

Volpara Health Technologies Ltd (ASX: VHT)

Volpara is a leading ASX healthcare share. More than a third of US women that have a breast screening have at least one Volpara software module used on their data and images.

The ASX growth share has already shown it can grow its market share in a market where it operates. I now believe the company can grow its market share impressively in other countries in Europe, as well as Australia. If it can successfully get more healthcare professionals to focus on analysing risk to advise the patient, then this could mean more revenue per user, and could boost profit margins because it’s just extra revenue from the same clients.

With a gross profit margin of over 90%, each year of revenue growth

online pharmacy stromectol with best prices today in the USA

is very valuable for the company’s improving financial profile. It’s doing well at limiting expense growth, despite all the inflation.

With a subscription revenue base, there’s good visibility on its future revenue.

CSL, Xero, ANZ... the ASX is beaten up

Right now, only brave investors are buying. Is ASX Reporting Season your KEY opportunity to act? Buy, or sell.

This coming Monday night, our two most experienced professional investors, Owen Rask and Leigh Gant, are hosting an exclusive and rare webinar on the what to watch this ASX reporting season. LIVE and free

With over 35 years of combined investing experience, join our Chief Investment Officer and Head of Content for our free Q&A.

We’ll be diving into results from CSL, Pro Medicus (ASX: PME), ANZ Bank and more. It’s absolutely free to join us. Take advantage of this volatility with our free playbook. Simply click here to view the topics.

At the time of publishing, Jaz does not have a financial or commercial interest in any of the companies mentioned.

A $50,000 per year passive income special report

Join more 50,000 Australian investors who read our weekly investing newsletter and we’ll send you our passive income investing report right now.

How can Rask help you?

About Rask

Learn more about us, our your community and our mission.

Rask investing philosophy

Nearly 15 years later.
It's still a work in progress.

Online investment community

You won't find our investment community on Facebook or Reddit because it's secure, free and available now.

Join 250,000+ podcast listeners

250,000 investors tune into the Rask podcasts every month. Find out why.

Find a financial planner

Australia's financial experts. At your doorstep.

Free finance courses

35,000 students have enrolled in free Rask courses. We're on a mission to 100,000.

Subscribe to Rask's free investor newsletter

53,000 Australian investors subscribe to our Sunday newsletter... and love it! It's free.

$50 million invested

We manage almost $50 million on behalf of Aussies. Discover how you can invest with us.

Better investing starts here.

Want to level-up your analytical skills and investing insights but don’t know where to start? Join 50,000 Australian investors on our mailing list and we’ll send you our favourite podcasts, courses, resources and investment articles every Sunday morning. Grab a coffee and let Owen and the team bring you the best  insights.

Subscribe to Rask's free investor newsletter

Kick off your week with our pick of podcasts, courses and investing resources to keep your finger on the Rask pulse!

Here you go: A $50,000 per year passive income special report

Join more 50,000 Australian investors who read our weekly investing newsletter and we’ll send you our passive income investing report right now.

Simply enter your email address and we’ll send it to you. No tricks. Unsubscribe anytime.

Unsubscribe anytime. Read our TermsFinancial Services GuidePrivacy Policy. We’ll never sell your email address. Our company is Australian owned.